Move over, CBD. Forget terpenes. It looks like the next big thing in the rapidly evolving, ever-expanding world of cannabis is going to be flavonoids.

Why's that? Because, despite the fact that studies are only just getting off the ground, "cannflavin" (cannabis flavonoids) research is already raising hopes that we might one day have a whole new way to treat pain.

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has launched CX Industries Inc. (“CX Industries” or “CX”), a wholly-owned subsidiary that will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility.

From cannabis-infused gin to ice cream, the legalization of marijuana in various parts of the world is opening up an entirely new industry. Whatever your views on this recreational drug, there can be no doubt that many companies will spring up and capitalize on this new potentially lucrative opportunity.

Some are ready to call it quits on the cannabis market.

But the Green Revolution has only just gotten started.

The big plays—Canopy Growth Corp, Aurora, Cronos Group—saw big gains in 2017 but slowed down in 2018 and seem to have stalled in 2019.

Some worry that it’s just a big bubble—but they’re not looking closely enough.

There are plenty of opportunities for investors looking to cash in on the cannabis boom—and TruTrace Technologies (CSE:TTT, OTCMKTS:BKKSF) is one of them.

In June, California cannabis company Harborside Health ventured north and became the 66th US pot business to list its stock on the Canadian Securities Exchange.

The driving force behind the migration is simple: Marijuana sales are legal at the federal level in Canada, but remain illegal in the US. The federal ban means American cannabis businesses can’t list on US exchanges or raise capital from investors, as long as they sell in their home country.

Seattle-based cannabis website Leafly is expanding its order and delivery system that first launched March 2018 in the U.S., to Canada. Dubbed Leafly Pickup, this function operates pretty much the way it has stateside: Customers check out the menus of participating cannabis retailers, order what they want and then pick up the products directly in-store from the retailer.

ParcelPal Technology Inc. (CSE:PKG) (OTC:PTNYF), an online delivery service, is partnering with Shopify to improve the way people shop for cannabis online. ParcelPal will be integrating their delivery app with Shopify’s platform over the coming weeks. When it launches, Canadian LPs already on Shopify will be able to use the new app to deliver both medical and recreational cannabis across the territories.

CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing THC BioMed (CSE: THC) (OTCQX: THCBF).

The cannabis industry is in the midst of a period of unprecedented innovation. Cannabis is becoming a legal consumer product in a growing number of jurisdictions at the same time as innovators are making major breakthroughs in business and agricultural technology.

As a result, we’re seeing the development of cutting edge tech to make cannabis production more efficient, more affordable and more productive.

A prime example of technological innovation disrupting the cannabis industry is the emergence of AI for smart cultivation and production.

Shoppers to leverage blockchain tech to get doctors on board with medical marijuana prescriptions